Tadalafil Tablet, Film Coated
Product Images NDC 71821-006

Product Visual Gallery

This gallery contains 18 technical images submitted to the FDA as part of the official labeling for Tadalafil (NDC 71821-006). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Vkt Pharma Private Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Tadalafil-tablets-figure-1 (Tadalafil Tablets Figure 1)

This is a chart showing the difference (in mmHg) between Tadalafil and Placebo for standing systolic and diastolic blood pressure, as well as supine systolic and diastolic blood pressure over time (in hours).*

FDA Label Image

Tadalafil-tablets-figure-2 (Tadalafil Tablets Figure 2)

FDA Label Image

Tadalafil-tablets-figure-3 (Tadalafil Tablets Figure 3)

This appears to be a table displaying the change in systolic blood pressure (in mmHg) after the administration of different treatments at different times. The treatments include tadalafil and doxazosin, and there are both active and placebo versions of these treatments. The table shows the measurements at 20 minutes and 10 minutes after administration of each treatment.*

FDA Label Image

Tadalafil-tablets-figure-4 (Tadalafil Tablets Figure 4)

This is a graph that shows the plasma concentration of Tadalafil in micrograms per liter (ug/L) over time in hours. Three different treatments are compared: a single 20-mg dose, a single 5-mg dose, and once-daily 5-mg dose after 5 consecutive days of administration. The x-axis shows the time in hours and the y-axis shows the plasma concentration of Tadalafil. There is a consistent increase in plasma concentration in all three treatments over time.*

FDA Label Image

Tadalafil-tablets-figure-5 (Tadalafil Tablets Figure 5)

FDA Label Image

Tadalafil-tablets-figure-6 (Tadalafil Tablets Figure 6)

The text is not-available as it contains only a few incomplete words and symbols.*

FDA Label Image

Tadalafil-tablets-figure-7 (Tadalafil Tablets Figure 7)

FDA Label Image

Tadalafil-tablets-figure-8 (Tadalafil Tablets Figure 8)

FDA Label Image

Chemical Structure (Tadalafil Tablets Structure)

FDA Label Image

Tadalafin Tablets,usp,10 mg (NDC-71821-008-01)

This is a description of a medication with the NDC code 71821-008-01. The medication contains Tadalafil USP 10 mg and is in the form of a film-coated tablet. The tablets should be stored at room temperature (25°C) and kept in a tight container. It is important to keep these tablets out of the reach of children, and the tablets should not be split. No dosage instructions are provided here, and the accompanying literature should be consulted for that information. The tablets are manufactured by VKT Pharma Private Limited in Srikakulam, India. Details for the batch code can be found in a specific area on the packaging.*

FDA Label Image

Tadalafin Tablets,usp,20 mg (NDC-71821-009-01)

NDC 71821-009-01 is a medication containing Tadalafil USP 20 mg available as film-coated tablets. It is advised not to split the tablets, and the entire dosage should be taken as directed. The recommended dosage can be found in the literature provided with the medication. The tablets should be stored in a tight container within the temperature range of 15°C to 30°C (59° to 86° F). This medication should be kept out of reach of children. The batch code details for this medication can be found in the unvarnished area provided. It is manufactured by VKT Pharma Private Limited in Srikakulam, India.*

FDA Label Image

Tadalafin Tablets,usp,2.5 mg (NDC-71821-006-01 Blister Label)

This is a description of Tadalafil Tablets, USP containing 15 film-coated tablets with 2.5mg of tadalafil each for once-daily use, with instructions to refer to accompanying literature for dosage. It is manufactured by VKT Pharma Private Limited in India and should be stored at room temperature and kept out of reach of children. It warns not to split tablets and take the entire dose.*

FDA Label Image

Tadalafin Tablets,usp,2.5 mg (NDC-71821-006-01)

FDA Label Image

Tadalafin Tablets,usp,5 mg (NDC-71821-007-02)

This is a package of Tadalafil Tablets USP intended for oral use. Each package contains 30 film-coated tablets with a strength of 5 mg of Tadalafil USP. The label warns users not to split the tablets and to take the entire dose. The accompanying literature should be consulted for information on recommended dosages. The tablets should be stored at room temperature not exceeding 30°C with permitted excursions to 15°C to 30°C. The product should be kept out of reach of children and dispensed in a tight container. Manufacturers of the product are VKT Pharma Private Limited, located in Srikakulam, India. The batch code details are available on an unvarnished area of the package.*

FDA Label Image

Tadalafin Tablets,usp,5 mg (NDC-71821-007-01)

This is a description of a medicine called Tadalafil Tablets, USP. The usual dosage is one tablet daily, and each tablet contains a certain amount of tadalafil. The medication should be stored at a specific temperature and should be kept out of the reach of children. The tablets should not be split and the entire dose should be taken. The medicine is manufactured by a company called VKT Pharma Private Limited located in Srikakulam, India. Additionally, there is a code number (NDC 71821-007-01) and lot number (Exp./Lot WKT 718217007) provided.*

FDA Label Image

Tadalafin Tablets,usp,5 mg (NDC-71821-007-01)

This is a description of Tadalafil Tablets, USP for once daily use. It should be taken as one dose without splitting the tablets. The package contains 30 tablets in 2 blisters of 15 each. The NDC number is 71821-007-01. The rest of the text is not-available due to errors.*

FDA Label Image

Vkt-pharma-logo-1 (Vkt Pharma Logo 1)

FDA Label Image

Vkt-pharma-logo (Vkt Pharma Logo 2)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.